J 
3,645
-0.14%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩55.17bn
FY2020FY2025
Net income
−₩7.44bn
FY2020FY2025
Free cash flow
−₩9.67bn
FY2020FY2025
Shareholders' equity
₩170.23bn
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | ₩55.17bn | ₩82.87bn | ₩114.49bn | ₩67.66bn | ₩78.70bn | ₩47.14bn |
| Gross profit | ₩12.24bn | ₩10.86bn | ₩24.14bn | ₩3.39bn | ₩227.6m | ₩2.64bn |
| Research and development | ₩1.74bn | ₩774.6m | ₩897.9m | ₩701.7m | ₩569.1m | ₩246.2m |
| Operating income | −₩5.25bn | −₩5.44bn | ₩11.94bn | −₩6.90bn | −₩3.81bn | ₩1.47bn |
| Net income | −₩7.44bn | −₩8.87bn | ₩17.42bn | −₩5.69bn | −₩14.61bn | ₩980.1m |
| Diluted earnings per share | -249.63 | -297.58 | 593.13 | -181.51 | -582.75 | 35.96 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | ₩207.58bn | ₩222.58bn | ₩196.54bn | ₩84.82bn | ₩87.76bn | ₩52.08bn |
| Cash and short-term investments | — | ₩41.11bn | ₩26.95bn | ₩19.06bn | — | ₩2.57bn |
| Total liabilities | ₩37.35bn | ₩44.15bn | ₩61.87bn | ₩25.98bn | ₩60.75bn | ₩34.81bn |
| Debt | ₩25.47bn | ₩28.94bn | ₩27.38bn | ₩14.60bn | ₩9.37bn | ₩25.47bn |
| Shareholders' equity | ₩170.23bn | ₩178.43bn | ₩134.67bn | ₩58.84bn | ₩27.01bn | ₩17.27bn |
| Shares outstanding | 30m | 30m | 29m | 31m | 25m | 27m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | ₩872.1m | −₩4.91bn | ₩27.63bn | ₩3.07bn | ₩196.0m | −₩6.65bn |
| Capital spending | −₩10.55bn | −₩32.50bn | −₩87.25bn | −₩17.47bn | −₩7.62bn | −₩3.42bn |
| Free cash flow | −₩9.67bn | −₩37.40bn | −₩59.62bn | −₩14.40bn | −₩7.42bn | −₩10.07bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩8.93bn | ₩7.17bn | ₩9.37bn | ₩15.86bn | ₩18.95bn | ₩11.00bn | ₩14.79bn | ₩20.32bn |
| Gross profit | ₩1.37bn | ₩32.8m | ₩767.2m | ₩4.15bn | −₩37.4m | ₩4.74bn | −₩4.72bn | ₩1.12bn |
| Operating income | −₩1.50bn | −₩819.8m | −₩4.52bn | −₩1.70bn | −₩1.00bn | ₩170.2m | −₩6.42bn | −₩675.3m |
| Net income | −₩2.48bn | −₩394.3m | −₩3.55bn | −₩173.6m | −₩4.11bn | ₩391.9m | −₩9.76bn | −₩951.9m |
| Diluted earnings per share | -83.05 | -13.22 | -119.14 | -5.82 | -137.81 | 13.14 | -327.35 | -32.19 |
| Cash from operations | ₩3.05bn | ₩65.0m | −₩1.09bn | ₩277.0m | ₩1.61bn | ₩78.0m | −₩4.91bn | −₩2.51bn |
| Capital spending | −₩589.0m | −₩499.0m | −₩1.27bn | −₩3.78bn | −₩2.22bn | −₩3.26bn | −₩32.50bn | −₩20.97bn |
| Free cash flow | ₩2.46bn | −₩434.0m | −₩2.36bn | −₩3.51bn | −₩618.0m | −₩3.18bn | −₩37.40bn | −₩23.48bn |
| Total assets | ₩202.87bn | ₩202.96bn | ₩207.58bn | ₩214.61bn | ₩216.61bn | ₩218.88bn | ₩222.58bn | ₩238.52bn |
| Cash and short-term investments | — | — | — | — | — | ₩37.95bn | ₩41.11bn | ₩53.10bn |
| Debt | ₩21.47bn | ₩23.75bn | ₩25.47bn | ₩26.31bn | ₩27.16bn | ₩28.19bn | ₩28.94bn | ₩29.17bn |
| Shareholders' equity | ₩167.40bn | ₩169.84bn | ₩170.23bn | ₩174.45bn | ₩174.56bn | ₩178.88bn | ₩178.43bn | ₩187.73bn |
Financial ratios
Data as of 3 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 22.2% | 13.1% | 21.1% | 5.0% | 0.3% |
| Operating margin | -9.5% | -6.6% | 10.4% | -10.2% | -4.8% |
| Net margin | -13.5% | -10.7% | 15.2% | -8.4% | -18.6% |
| Return on equity | -4.4% | -5.0% | 12.9% | -9.7% | -54.1% |
| Return on assets | -3.6% | -4.0% | 8.9% | -6.7% | -16.6% |
| Revenue growth | -33.4% | -27.6% | 69.2% | -14.0% | — |
| Earnings growth | -16.1% | -150.9% | -406.3% | -61.1% | — |
| Current ratio | 5.43x | 4.25x | 1.52x | 3.09x | 2.74x |
| Debt to equity | 0.15x | 0.16x | 0.20x | 0.25x | 0.35x |
| Equity ratio | 82.0% | 80.2% | 68.5% | 69.4% | 30.8% |
| Interest coverage | -7.82x | -10.32x | 13.45x | -8.44x | -3.61x |
| R&D as a share of sales | 3.2% | 0.9% | 0.8% | 1.0% | 0.7% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -6.6% | 3.2% | — |
| Operating income | -8.7% | — | — |
| Net income | 9.4% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 16.7% | 15.8% | 12.0% | — |
| Operating margin | -7.7% | -1.8% | -1.8% | — |
| Net margin | -11.8% | -1.4% | -4.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | -28.1 | -46.9 | 46.2 |
| Price to sales | 3.8 | 5.0 | 7.0 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.